Etomidate use in severe sepsis and septic shock patients does not contribute to mortality. - Wikidata - awgldk - TriplyDB

Etomidate use in severe sepsis and septic shock patients does not contribute to mortality.

Etomidate use in severe sepsis and septic shock patients does not contribute to mortality.

http://www.wikidata.org/entity/Q37851869

about

Effects of continuous infusion of etomidate at various dose rates on adrenal function in dogs.Anesthetic Pharmacology and the Morbidly Obese Patient.The role of etomidate as an anaesthetic induction agent for critically ill patients.

P2860

Q35888427-DC619096-A851-449D-B874-A36CAEFFD9C9 Q36697500-33A92B60-C079-442E-A918-963B75F45B9F Q38831520-64FDAE2F-1449-4972-B366-5D7C6391C944

P2860

Etomidate use in severe sepsis and septic shock patients does not contribute to mortality.

http://www.wikidata.org/entity/Q37851869

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 11 March 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Etomidate use in severe sepsis ...... s not contribute to mortality.

@en

Etomidate use in severe sepsis ...... s not contribute to mortality.

@nl

type

label

Etomidate use in severe sepsis ...... s not contribute to mortality.

@en

Etomidate use in severe sepsis ...... s not contribute to mortality.

@nl

prefLabel

Etomidate use in severe sepsis ...... s not contribute to mortality.

@en

Etomidate use in severe sepsis ...... s not contribute to mortality.

@nl

P1433

Q37851869-9960817E-9766-45DB-B0EA-01F91B0B3131

P1476

Q37851869-EA56FE17-0E59-451D-902A-AA3C391AA5A9

P2093

Q37851869-21AE1035-A23F-4DAE-A3AF-9061A3F75CCC

Q37851869-2F376A2F-57D9-461A-96B2-1CEB8F7EDA7B

Q37851869-43A030A8-06A2-449C-86A2-7028A86151FA

Q37851869-47AF3086-84D9-4026-B3E1-D67C6FD60F84

Q37851869-A69C8451-80CC-48E5-B950-B214DCE7255A

Q37851869-A764395A-4CD7-4D01-A91C-864FB6E2A6BC

Q37851869-A940E551-C3C2-4D4B-9372-323E02BFD8D3

Q37851869-EF35A596-FD2D-45FE-A565-FCE73CE3614C

Q37851869-F0F93F17-B6E4-4FF2-B46E-CEBABBBECD37

P2860

Q37851869-15A0DAF4-D560-4A21-9D61-C4DBBA94ECA6

Q37851869-1EDE4921-F105-4B76-9660-EA1E7424FD76

Q37851869-4F968908-2E80-4315-811C-21E5FB60324A

Q37851869-85595B71-F40F-4732-A6FA-820190DEC941

Q37851869-865F746E-AF0C-4E51-9D73-28EA18205283

Q37851869-9C787E7B-6FDA-47D7-9138-76B575FA8378

Q37851869-A64FF540-77F3-4AF6-B489-08EF030FBEED

Q37851869-AA3743E8-265D-44CA-9A5A-7E0EF5C134CA

Q37851869-B02BAFF4-5E03-4EAE-B52C-DE4BC2C16C79

Q37851869-CDC257B7-11AD-4449-B03B-EA39E40C97AA

P2888

Q37851869-DE101B0B-3FB2-4F2D-ACA6-87AD17275547

P304

Q37851869-6E8CAD73-496F-47B5-BDF9-18C551FC65B7

P31

Q37851869-547F510C-8515-4651-A2D7-D7443E125010

P356

Q37851869-36A6247F-43B2-4F3F-8A8B-FDB9EFDB0657

P433

Q37851869-D4AD1DE6-F92E-4691-972B-F2DF220CC87B

P478

Q37851869-1F3C737C-322E-4C87-A824-5CD1604932F5

P577

Q37851869-9A4B78D2-A6AE-4555-B8D1-962D363FC631

P698

Q37851869-CD14DD00-F720-4B2D-BD27-D99DB30765D0

P921

Q37851869-3AC555ED-910A-4657-8483-C9D67419079B

P356

S11739-011-0553-3

P1433

Internal and emergency medicine

P1476

Etomidate use in severe sepsis ...... s not contribute to mortality.

@en

P2093

Afsaneh Lomax

http://www.w3.org/2001/XMLSchema#string

Alison Hayward

http://www.w3.org/2001/XMLSchema#string

Charles Wira

http://www.w3.org/2001/XMLSchema#string

Gregory Volturo

http://www.w3.org/2001/XMLSchema#string

Jean Marcelin

http://www.w3.org/2001/XMLSchema#string

Karin Przyklenk

http://www.w3.org/2001/XMLSchema#string

Marie Mullen

http://www.w3.org/2001/XMLSchema#string

Robert Ehrman

http://www.w3.org/2001/XMLSchema#string

Thomas Ellis

http://www.w3.org/2001/XMLSchema#string

P2860

Should we use etomidate as an induction agent for endotracheal intubation in patients with septic shock?: a critical appraisal

Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial

Adrenal insufficiency in meningococcal sepsis: bioavailable cortisol levels and impact of interleukin-6 levels and intubation with etomidate on adrenal function and mortality

Hydrocortisone therapy for patients with septic shock

Intubating conditions and hemodynamic effects of etomidate for rapid sequence intubation in the emergency department: an observational cohort study

Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.

The incidence of relative adrenal insufficiency in patients with septic shock after the administration of etomidate

Effect of induction agent on vasopressor and steroid use, and outcome in patients with septic shock

Adrenocortical dysfunction following etomidate induction in emergency department patients.

Risk factors of relative adrenocortical deficiency in intensive care patients needing mechanical ventilation.

P2888

s11739-011-0553-3

P304

253-257

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11739-011-0553-3

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21394520

http://www.w3.org/2001/XMLSchema#string

P921